Promising efficacy of berzosertib and irinotecan in pancreatic cancer
Liza Villaruz • 6 Jun 2022
Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Keep up to date with all the latest news with our monthly newsletter